Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
Romain Itier, Maéva Guillaume, Jean‐Etienne Ricci, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 2, pp. 789-798
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Virginia S. Hahn, Christopher Petucci, Minsoo Kim, et al.
Circulation (2023) Vol. 147, Iss. 15, pp. 1147-1161
Open Access | Times Cited: 128
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
Livnat Alon, Bernadette Corica, Valeria Raparelli, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 6, pp. 938-946
Open Access | Times Cited: 87
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease
Niki Katsiki, Genovefa Kolovou, Michal Vráblík
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta‐analysis
Zhiwei Yan, Yang Liu, Wei Li, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 11
Closed Access | Times Cited: 24
A novel controlled metabolic accelerator for the treatment of obesity‐related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trial
Dalane W. Kitzman, Gregory D. Lewis, Ambarish Pandey, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 5
Diagnosis and Management of Heart Failure
Inna P. Gladysheva, Ryan D. Sullivan
MDPI eBooks (2022)
Open Access | Times Cited: 21
Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
Yalin Cao, Siyu Guo, Yugang Dong, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 3, pp. 1771-1780
Open Access | Times Cited: 11
Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction
Xiao Liu, Wenya Chen, Wen Shao, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3985-3994
Open Access | Times Cited: 17
Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution
Li-You Lian, Chen‐Xiao Huang, Qin‐Fen Chen, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 2
Closed Access
Resistance Exercise in Treating Heart Failure with Preserved Ejection Fraction (HFpEF) and Obesity: Targeting Skeletal Muscle Abnormalities and Ectopic Adipose Depots
Daniel J. McDonough
Physiologia (2025) Vol. 5, Iss. 1, pp. 10-10
Open Access
Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis
Parham Dastjerdi, Mehrdad Mahalleh, Hedieh Shayesteh, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study
Jiyun Park, Gyuri Kim, Hasung Kim, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Heart failure with preserved ejection fraction and non‐alcoholic fatty liver disease: new insights from bioinformatics
Anzhu Wang, Qiang Li, Zhuo Sun, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 1, pp. 416-431
Open Access | Times Cited: 15
Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis
Athina Goliopoulou, Panagiotis Theofilis, Evangelos Oikonomou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14292-14292
Open Access | Times Cited: 7
Update on cirrhotic cardiomyopathy: from etiopathogenesis to treatment
Ogulcan Yumusak, Michael Doulberis
Annals of Gastroenterology (2024)
Open Access | Times Cited: 2
Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease
Jeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, et al.
Atherosclerosis (2023) Vol. 372, pp. 10-18
Open Access | Times Cited: 6
Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication
Masato Furuhashi, Atsuko Muranaka, Satoshi Yuda, et al.
The American Journal of Cardiology (2021) Vol. 158, pp. 139-146
Closed Access | Times Cited: 12
Association of Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis with Epicardial Adipose Tissue Volume and Atrial Deformation Mechanics in a Large Asian Population Free from Clinical Heart Failure
Yau‐Huei Lai, Cheng‐Huang Su, Ta‐Chuan Hung, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 916-916
Open Access | Times Cited: 8
Characterizing Heart Failure With Preserved Ejection Fraction in End-Stage Liver Disease and Liver Transplant Outcomes
Won‐Jung Shin, Hye‐Mee Kwon, Sung‐Hoon Kim, et al.
JACC Asia (2023) Vol. 3, Iss. 3, pp. 506-517
Open Access | Times Cited: 4
Diagnostic and prognostic value of NT-proBNP in patients with non-alcoholic fatty liver disease and acute decompensated heart failure
I A Misan, Olga S. Arisheva, И. В. Гармаш, et al.
Clinical pharmacology and therapy (2024) Vol. 33, Iss. 1, pp. 31-37
Open Access | Times Cited: 1
Kill two birds with one stone: Hapatologist’s approach to metabolic dysfunction-associated steatotic liver disease and heart failure
Y. Hirao, Clarke Morihara, Tomoki Sempokuya
World Journal of Cardiology (2024) Vol. 16, Iss. 11, pp. 660-664
Closed Access | Times Cited: 1
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
José Arriola-Montenegro, Renato Beas, Renato Cerna-Viacava, et al.
World Journal of Cardiology (2023) Vol. 15, Iss. 7, pp. 328-341
Open Access | Times Cited: 3
Metabolic Remodeling with Hepatosteatosis Induced Vascular Oxidative Stress in Hepatic ERK2 Deficiency Mice with High Fat Diets
Takehiko Kujiraoka, Kazuki Kagami, Toyokazu Kimura, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8521-8521
Open Access | Times Cited: 4
Candidate Screening for Heart Failure With Preserved Ejection Fraction Clinic by Fib-4 Index From Subclinical Subjects
Chisato Okamoto, Osamu Tsukamoto, Takuya Hasegawa, et al.
Gastro Hep Advances (2022) Vol. 2, Iss. 2, pp. 170-181
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top